DnaJ heat shock protein family (Hsp40) member C19 pseudogene 3Genealiases: []
Q-omics provides the consensus-scored DNAJC19P3 profile across patient tissues and cancer cell-line models. DNAJC19P3 expression is associated with patient survival in 7 of 34 cancer types, with the highest sampling consensus in THCA. Among the 18 cancer types available for tumor–normal comparison, DNAJC19P3 is differentially expressed in 3, with the highest sampling consensus in COAD. Additionally, DNAJC19P3 RNA expression shows 4,499 significant gene co-expression associations, with the highest sampling consensus in ESCA. Together, these results highlight THCA, COAD, and ESCA as cancer lineages where DNAJC19P3 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for DNAJC19P3 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes DNAJC19P3 survival associations across molecular data types. DNAJC19P3 RNA expression shows survival associations in the most cancer types (7). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible DNAJC19P3 RNA expression–survival associations across cancer types. High DNAJC19P3 expression shows unfavorable associations in THCA, SKCM, THYM, BLCA and LUAD, but favorable associations in ESCA. The THCA Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify THCA as the clearest survival context for DNAJC19P3 RNA expression.
This table summarizes DNAJC19P3 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 3. The strongest signals are observed in COAD for RNA.
This table ranks reproducible tumor–normal expression differences for DNAJC19P3. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. DNAJC19P3 shows lower tumor expression in COAD, HNSC and READ. The COAD box plot shows higher DNAJC19P3 RNA expression in normal versus tumor tissue (log2 FC = −0.274, t-test p < 0.001).
This table shows molecular features associated with DNAJC19P3 in patient tissues and cancer cell lines. In patient samples, DNAJC19P3 shows the broadest associations at the RNA and protein expression levels, with ESCA recurring as the lineage with the largest associated feature set.
